# CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer

> **NCT00033384** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** CI-1040

## Key facts

- **NCT ID:** NCT00033384
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** — (—)
- **Last updated:** 2013-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00033384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00033384, "CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00033384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*